Published in Circulation on August 28, 2001
Nocturnal peak in atrial tachyarrhythmia occurrence as a function of arrhythmia burden. J Cardiovasc Electrophysiol (2012) 1.45
Genetic mechanisms of atrial fibrillation: impact on response to treatment. Nat Rev Cardiol (2013) 1.11
Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation. J Interv Card Electrophysiol (2004) 0.82
Pacing for atrial fibrillation. Heart (2003) 0.82
A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers. J Interv Card Electrophysiol (2015) 0.80
The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough? J Interv Card Electrophysiol (2003) 0.77
Is dual defibrillator better than conventional DDD pacing in brady-tachy syndrome? Results of the ICARUS Trial (Internal Cardioversion Antitachypacing and Prevention: Resource Utilization Study). J Interv Card Electrophysiol (2006) 0.76
The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight? J Cardiovasc Pharmacol (2016) 0.76
Hybrid therapy of atrial fibrillation: algorithms and outcome. J Interv Card Electrophysiol (2003) 0.75
Selecting dual chamber or single chamber implantable defibrillators: what is the golden rule? Indian Pacing Electrophysiol J (2003) 0.75
Clinical trials of pacing for maintenance of sinus rhythm. J Interv Card Electrophysiol (2004) 0.75
Atrial fibrillation: the role of atrial defibrillation. J Interv Card Electrophysiol (2003) 0.75
The impact of atrial prevention and termination therapies on atrial tachyarrhythmia burden in patients receiving a dual-chamber defibrillator for ventricular arrhythmias. J Interv Card Electrophysiol (2004) 0.75
[Not Available]. Herzschrittmacherther Elektrophysiol (2002) 0.75
Cardiac resynchronization therapy in clinical practice: need for electrical, mechanical, clinical and logistic synchronization. J Interv Card Electrophysiol (2007) 0.75
[Sandwiched between the single- and triple-chamber ICD: do we still need the dual-chamber ICD?]. Herzschrittmacherther Elektrophysiol (2008) 0.75
The role of pacing in rhythm control and management of atrial fibrillation. J Interv Card Electrophysiol (2007) 0.75
Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene (2008) 3.92
Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol (2001) 3.83
Atrial arrhythmias after cardiothoracic surgery. N Engl J Med (1997) 3.46
The effects of a displayed cognitive aid on non-technical skills in a simulated 'can't intubate, can't oxygenate' crisis. Anaesthesia (2014) 2.73
Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol (1996) 2.27
Initial experience with mode switching in a dual sensor, dual chamber pacemaker in patients with paroxysmal atrial tachyarrhythmias. Pacing Clin Electrophysiol (1994) 2.08
Exercise-induced ST segment elevation in Q wave leads in postinfarction patients: defining its meaning and utility in today's practice. Cardiology (2000) 2.04
A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation (1993) 2.03
Cardiac rupture, a clinically predictable complication of acute myocardial infarction: report of 70 cases with clinicopathologic correlations. J Am Coll Cardiol (1993) 1.99
Effect of definition on incidence of postinfarction pericarditis. It is time to redefine postinfarction pericarditis? Circulation (1994) 1.80
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood (1999) 1.58
Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol (2001) 1.56
Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loops. J Thorac Cardiovasc Surg (2004) 1.55
Clinical features of amiodarone-induced pulmonary toxicity. Circulation (1990) 1.49
Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. Am J Cardiol (1995) 1.48
Distribution of patients' paroxysmal atrial tachyarrhythmia episodes: implications for detection of treatment efficacy. J Cardiovasc Electrophysiol (2001) 1.47
Effects of slow pathway ablation on fast pathway function in patients with atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol (1997) 1.44
Common genetic variation near the connexin-43 gene is associated with resting heart rate in African Americans: a genome-wide association study of 13,372 participants. Heart Rhythm (2012) 1.43
Electrocardiographic diagnosis of postinfarction regional pericarditis. Ancillary observations regarding the effect of reperfusion on the rapidity and amplitude of T wave inversion after acute myocardial infarction. Circulation (1993) 1.42
Torsades de pointes ventricular tachycardia associated with overdose of astemizole. Mayo Clin Proc (1994) 1.41
Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med (2001) 1.38
Effects of induced electric fields on finite neuronal structures: a simulation study. IEEE Trans Biomed Eng (1993) 1.37
Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators. Circulation (2000) 1.37
Intra-atrial conduction block along the mitral valve annulus during accessory pathway ablation: evidence for a left atrial "isthmus". J Cardiovasc Electrophysiol (2001) 1.36
Reentrant ventricular arrhythmias in the late myocardial infarction period in the dog. 13. Correlation of activation and refractory maps. Circ Res (1985) 1.35
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood (2001) 1.32
Reduced verapamil clearance during long-term oral administration. Clin Pharmacol Ther (1981) 1.31
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer. Oncogene (2010) 1.29
Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation. J Am Coll Cardiol (1997) 1.24
Indications, effectiveness, and long-term dependency in permanent pacing after cardiac surgery. Am J Cardiol (1997) 1.22
Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin. J Am Coll Cardiol (1984) 1.19
Randomized prospective pilot study of long-term dual-site atrial pacing for prevention of atrial fibrillation. Mayo Clin Proc (1998) 1.17
How accurate is cancer scan reporting? Hosp Med (2000) 1.12
Vasovagal syncope. Ann Intern Med (2000) 1.11
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation. Bone Marrow Transplant (1999) 1.11
Triggered ventricular rhythms in 1-day-old myocardial infarction in the dog. Circ Res (1983) 1.08
The accuracy of serum chlamydial antibodies in the diagnosis of tubal pathology: a meta-analysis. Fertil Steril (1997) 1.08
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation. Blood (1996) 1.08
Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias. Am Heart J (1977) 1.07
A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation (1993) 1.05
Neutral and acidic oligosaccharides in Holstein-Friesian colostrum during the first 3 days of lactation measured by high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry. J Dairy Sci (2010) 1.04
Global right atrial mapping of human atrial flutter: the presence of posteromedial (sinus venosa region) functional block and double potentials : a study in biplane fluoroscopy and intracardiac echocardiography. Circulation (2000) 1.03
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood (1995) 1.03
Effects of hormones on the synthesis of alpha 1 (acute-phase) glycoprotein in isolated rat hepatocytes. Biochem J (1977) 1.03
Comparison of cathodal, anodal, and bipolar strength-interval curves with temporary and permanent pacing electrodes. Br Heart J (1979) 1.03
The effect of fish and omega-3 LCPUFA intake on low birth weight in Indian pregnant women. Eur J Clin Nutr (2007) 1.03
Survival and functional independence after implantation of a permanent pacemaker in octogenarians and nonagenarians. A population-based study. Ann Intern Med (1996) 1.02
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome. J Clin Oncol (1998) 1.02
Electrophysiology and endocardial mapping of induced atrial fibrillation in patients with spontaneous atrial fibrillation. Am J Cardiol (1999) 1.02
A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans. J Am Coll Cardiol (1989) 1.01
Consistent subcutaneous prepectoral implantation of a new implantable cardioverter defibrillator. Mayo Clin Proc (1994) 1.00
Is sinus node modification appropriate for inappropriate sinus tachycardia with features of postural orthostatic tachycardia syndrome? Pacing Clin Electrophysiol (2001) 1.00
Ventricular activation patterns of spontaneous and induced ventricular rhythms in canine one-day-old myocardial infarction. Evidence for focal and reentrant mechanisms. Circ Res (1982) 1.00
Pneumothorax: an unusual cause of ICD defibrillation failure. Pacing Clin Electrophysiol (1998) 1.00
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplant (1997) 1.00
The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol (1999) 1.00
Electrophysiologic testing in the upright position: improved evaluation of patients with rhythm disturbances using a tilt table. J Am Coll Cardiol (1984) 0.99
Heart rate variability: technique and investigational applications in cardiovascular medicine. Mayo Clin Proc (1995) 0.97
The effect of whey protein-enriched fractions on the physical and sensory properties of frankfurters. Meat Sci (2005) 0.97
Adenosine: potential modulator for vasovagal syncope. J Am Coll Cardiol (1996) 0.97
Reentrant ventricular arrhythmias in the late myocardial infarction period. 9. Electrophysiologic-anatomic correlation of reentrant circuits. Circulation (1983) 0.96
Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol (1997) 0.96
Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment. Mayo Clin Proc (1996) 0.96
Clinical diagnosis and risk stratification in patients with Brugada syndrome. J Am Coll Cardiol (2001) 0.95
The electrocardiographic diagnosis of regional pericarditis in acute inferior myocardial infarction. Eur Heart J (1993) 0.95
Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation (2001) 0.95
Autonomic cardiovascular control during hypoxia in the dog. Circ Res (1979) 0.95
Reentrant ventricular arrhythmias in the late myocardial infarction period. Interruption of reentrant circuits by cryothermal techniques. Circulation (1983) 0.94
Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators? J Cardiovasc Electrophysiol (2000) 0.94
Comparison of standard and irrigated radiofrequency ablation in the canine ventricle. J Cardiovasc Electrophysiol (1998) 0.94
Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial. DAPPAF Phase 1 Investigators. J Interv Card Electrophysiol (1998) 0.93
Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location. Circulation (1993) 0.93
Cardiac involvement in Behçet's disease. Arthritis Rheum (1985) 0.93
Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion. Bone Marrow Transplant (1997) 0.93
Comparison of results in two implantable defibrillators. Jewel 7219D Investigators. Am J Cardiol (1998) 0.92
Late potentials on signal-averaged electrocardiograms and patency of the infarct-related artery in survivors of acute myocardial infarction. J Am Coll Cardiol (1991) 0.92
Effects of high-frequency atrial pacing in atypical atrial flutter and atrial fibrillation. J Interv Card Electrophysiol (1997) 0.92
Desynchronization of epileptiform activity by extracellular current pulses in rat hippocampal slices. J Physiol (1994) 0.92
Five-year follow-up of 589 patients treated with amiodarone. Am Heart J (1993) 0.91
Tachycardia induced myocardial dysfunction. A reversible phenomenon? Br Heart J (1985) 0.91
Evaluation of right atrial and biatrial temporary pacing for the prevention of atrial fibrillation after coronary artery bypass surgery. J Am Coll Cardiol (1999) 0.90
Vulnerability of the mildly ischemic ventricle to cathodal, anodal, and bipolar stimulation. Circ Res (1977) 0.90
Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol (1987) 0.90
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma. Ann Oncol (1999) 0.90
Reprocessing of electrophysiology catheters: clinical studies, regulations, and recommendations. A report of the NASPE Task Force on Reprocessing of Electrophysiological Catheters. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol (2001) 0.89
Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardiol (1995) 0.89
Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol (1992) 0.88
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients. Biol Blood Marrow Transplant (1997) 0.88
Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics. Circulation (1982) 0.88
Defibrillation thresholds are increased by right-sided implantation of totally transvenous implantable cardioverter defibrillators. Pacing Clin Electrophysiol (1999) 0.88
Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode. Circulation (1994) 0.88
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue. Gynecol Oncol (1997) 0.87